Cargando…
Increased ATF2 expression predicts poor prognosis and inhibits sorafenib-induced ferroptosis in gastric cancer
Sorafenib, a tyrosine kinase inhibitor, has an important antitumor effect as a ferroptosis inducer in multiple cancers, including gastric cancer (GC). However, the status of sorafenib as a ferroptosis inducer has recently been questioned. There is very limited information about the relationship betw...
Autores principales: | Xu, Xin, Li, Yaxian, Wu, Youliang, Wang, Mingliang, Lu, Yida, Fang, Ziqing, Wang, Huizhen, Li, Yongxiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9723522/ https://www.ncbi.nlm.nih.gov/pubmed/36473315 http://dx.doi.org/10.1016/j.redox.2022.102564 |
Ejemplares similares
-
High ATF4 Expression Is Associated With Poor Prognosis, Amino Acid Metabolism, and Autophagy in Gastric Cancer
por: Wang, Mingliang, et al.
Publicado: (2021) -
INPP4B exerts a dual role in gastric cancer progression and prognosis
por: Wu, Youliang, et al.
Publicado: (2021) -
A signature of seven immune‐related genes predicts overall survival in male gastric cancer patients
por: Xu, Xin, et al.
Publicado: (2021) -
MGST1 Expression
Is Associated with Poor Prognosis,
Enhancing the Wnt/β-Catenin Pathway via Regulating AKT and Inhibiting
Ferroptosis in Gastric Cancer
por: Li, Yaxian, et al.
Publicado: (2023) -
Metformin promotes ferroptosis and sensitivity to sorafenib in hepatocellular carcinoma cells via ATF4/STAT3
por: Hu, Zongqiang, et al.
Publicado: (2023)